Elizabeth Gargill
Senior Director, Marketing and Public Relations
Rob Laurens, Chief Patient and Provider Officer
Regulation (EU) No 536/2014 (Clinical Trials Regulation) replaces the Clinical Trials Directive 2001/20/EC and looks to ensure a unified set of rules for the conduct of clinical trials throughout the European Union (EU). While the regulation aims to harmonize the conduct of clinical trials in the EU, sponsors will need to rethink and accelerate their patient recruitment planning. Discover some immediate steps you can take.
Dena Raffa, Senior Director, TCN Technologies
The Food and Drug Administration (FDA) will soon require clinical trial sponsors to submit a plan for improving diversity among clinical trial participants. While enhancing diversity, equity and inclusion (DEI) has been a topic of discussion in the industry for many years, sponsors will soon have an imperative to act. Learn how data, tech-enabled solutions and engagement platforms can help you achieve new DEI enrollment goals and objectives.
In this dynamic Q&A in the Patients as Partners in Clinical Research newsletter, BBK co-founder Bonnie A. Brescia discusses how patient-centricity in recruitment and retention has evolved and how companies can adapt their activities. Bonnie highlights the importance of bringing patient and caregiver insights to the industry, mitigating challenges in access, and identifying and supporting patient preferences.
Martin Lawlor, Senior Executive, Corporate Services
Organizations conducting clinical trials have long relied upon the data gathered by third-party cookies to identify potential subjects during patient recruitment. Apple eliminated third-party cookies from its Safari browser in 2017, and Mozilla stopped collecting cookies in its Firefox browser in 2019. Even though Google’s current plan does not proactively block third-party cookies until 2024, now is the time to begin adapting your strategies for identifying potential clinical trials participants.